Navigation Links
DU Test Finds UK Troops Uranium Free

A test developed by a team led by a University of Leicester geologist was recently used by the UK government’s Independent Depleted Uranium// Oversight Board to detect exposure of UK troops to depleted uranium (DU) during the 1991 Gulf Conflict.

Randall Parrish, Professor of Isotope Geology, developed the test with Postdoctoral Fellow Dr Axel Gerdes, who now works at the University of Frankfurt, Germany, and his colleague Matt Horstwood at the British Geological Survey, using advanced mass spectrometry.

Prof Parrish’s team has tested more than 350 individuals as part of the programme, with the result that none so far tested had any demonstrable DU exposure resulting from their participation in the 1991 Gulf Conflict, though the extent of actual initial exposure of tested individuals to DU is unknown.

Depleted uranium (DU) is a by-product from the manufacture of enriched uranium, used for fuel in nuclear reactors or in weapons. It is 60 per cent as radioactive as natural uranium.

Because of its hardness, it has been used in engineering projects, as well as in the construction of military tanks and anti-tank weapons, such as those used in the 1991 Gulf War, in Bosnia in 1994-5, Kosovo in 1999 and in the latest conflict in Iraq .

While DU weapons can reduce casualties amongst the forces using them, there may be long-term risks to the health of those exposed to them, either through shrapnel wounds or inhalation, and risks, also, to the environment.

The test was designed to detect after 15 years even a modest exposure to DU, on the basis of accepted knowledge about the retention and solubility of DU in the human body. The test is applicable even to those who excrete extremely low levels of uranium in urine.

Professor Parrish’s and his colleagues’ work, undertaken to help in the planning of the UK DU testing programme, explored the sensitivity and accuracy of urine tests t
'"/>




Page: 1 2

Related medicine news :

1. Its Never Too Late to Stop Smoking,Study Finds
2. Poll Finds Many Americans Misinformed About Cancer
3. Poll Finds Many Americans Misinformed About Cancer
4. Over Six Million HIV Infected People In South Africa- Finds A Survey
5. Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories
6. Study Finds No Link Between Statins And Breast Cancer Risk
7. Study Finds Low Socio-Economic Status Linked to Poor Dental Health
8. Australian Court Finds Man Guilty of Spreading HIV/AIDS
9. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
10. Expedition Everest Finds New Species
11. Study Finds Link Between Alcohol And Depression
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Test Finds Troops Uranium Free

(Date:10/8/2008)... HIV-test-kit.com is a new site aimed a....V. from the comfort and privacy of their own home... issue. It is hoped that through home tests more p...he AIDS virus. , New York...eople are getting more used to getting instant res...
(Date:10/8/2008)... Drug Information Association (DIA) wil...-7; Ottawa, Ontario, Canada) to discuss a number o...aceutical industry, health academia, and the healt... PA (PRWEB) October 8, 2008 -- The http://www.diah... host the http://www.diahome.org/diahome/FlagshipM...
(Date:10/8/2008)... AccurateAnswers™ support program...es for http://www.appointment-plus.com [online s... Scottsdale, AZ (PRWEB) October 8, 2008 -- ... scheduling software, continues to expand its soft...n most "software as a service" providers...
(Date:10/8/2008)... Juva Skin & Laser Center is well e...kin treatments in New York City. The facility is l...e, one of the latest skin resurfacing treatments t...e laser equipment. , New ...urgery and laser treatment industry is in the mids...
Breaking Medicine News(10 mins):Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Appointment-Plus Continues Innovation With Technical Support Program 2Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2
...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...
... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...
...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...
...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...
Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3
(Date:10/6/2008)... - Data Presented at ACG Annual Scient...ire/ -- Ironwood Pharmaceuticals,(formerly Microbi...r of,preclinical studies delineating the role that...leviating intestinal pain. These studies,demonstra...ical model of,intestinal hyperalgesia and desensit...
(Date:10/6/2008)... Experts Discuss Promising Research at The Amer... Annual Meeting, WASHINGTON, Oct. 6 /PRNewswir...n children and seniors was presented at The Americ...symposium, "Practical Applications of,Probiotics i...ields of,pediatrics, aging, and nutrition discusse...
(Date:10/6/2008)... PLYMOUTH MEETING, Pa., Oct. 6 /PRNewswire-Fi...oday reported data from its second Phase 1,clinica...d drug candidate,for the treatment of type 2 diabe...PTP1B, a validated molecular target that controls ...ys to normalize glucose and decrease,appetite. In ...
(Date:10/6/2008)... - Conference Call Scheduled for 9:0...tCall/ -- Dendreon Corporation (Nasdaq:,DNDN) anno...rim analysis of,the Phase 3, randomized, double-bl...Prostate AdenoCarcinoma Treatment, also known as D...y and efficacy of the,investigational active cellu...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 1Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 2Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 3Small Incisions Make Heart Valve Surgery Safer 918 1Small Incisions Make Heart Valve Surgery Safer 918 2Small Incisions Make Heart Valve Surgery Safer 918 3 26 239 3BDrug free treatments offer hope for older people in pain 915 1Medifast Announces Winners of Mother Daughter Challenge 912 1Medifast Announces Winners of Mother Daughter Challenge 912 2Medifast Announces Winners of Mother Daughter Challenge 912 3
...ested in Patients Reduces,Severity of Adult Leukae... the Danish,biopharmaceutical company, announced t...t of Bcl-2, has shown early evidence of,efficacy i...Lymphocytic Leukaemia (CLL). The results of the st...ting of the American Society of,Clinical Oncology,...
...7 - Inovio Biomedical,Corporation (AMEX:INO), focu... and infectious diseases and a novel alternative t...day the company,delivered multiple presentations o...ions relating to its electroporation-mediated DNA,...the American,Society of Gene Therapy (ASGT). Inovi...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 2Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 3Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 4Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 5
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: